Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

publishing date : 2022 - 03 - 01    entities : Abbvie inc.    save search

JAK Inhibitors Market to Grow by USD 12.05 billion | Increasing Number of Awareness Campaigns to Boost Growth | Technavio
Published: 2022-03-01 (Crawled : 00:00) - prnewswire.com
AZNCF | News | $140.3 -4.19% 1.5K twitter stocktwits trandingview |
Health Technology
| | O: 0.37% H: 2.02% C: 2.02%
NVSEF | News | $96.0 6.88% 52K twitter stocktwits trandingview |
Health Technology
| | O: 1.39% H: 0.0% C: 0.0%
ALPMY | News | $9.49 -1.11% 480K twitter stocktwits trandingview |
Manufacturing
| | O: -1.17% H: 0.68% C: 0.68%
NVS | News | $98.35 1.1% 0.0% 2.2M twitter stocktwits trandingview |
Health Technology
| | O: -1.55% H: 0.0% C: 0.0%
ABBV | News | $167.83 -1.01% 0.0% 4M twitter stocktwits trandingview |
Health Technology
| | O: -0.22% H: 2.4% C: 1.27%
GLPG | News | $28.78 -2.28% -2.33% 140K twitter stocktwits trandingview |
Health Technology
| | O: -2.66% H: 0.35% C: -1.83%
CTIC | $9.09 0.05% 11M twitter stocktwits trandingview |
Health Technology
| | O: 6.03% H: 13.88% C: 12.71%
AZN | News | $71.175 0.46% 0.46% 6.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.62% H: 0.0% C: 0.0%

growth
AbbVie Bolsters Neuro Platform with $1B Syndesi Buy
Published: 2022-03-01 (Crawled : 20:00) - biospace.com/
ABBV | News | $167.83 -1.01% 0.0% 4M twitter stocktwits trandingview |
Health Technology
| | O: 0.99% H: 0.0% C: 0.0%

platform
AbbVie Acquires Syndesi Therapeutics, Strengthening Neuroscience Portfolio
Published: 2022-03-01 (Crawled : 15:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.36% H: 0.0% C: 0.0%
ABBV | News | $167.83 -1.01% 0.0% 4M twitter stocktwits trandingview |
Health Technology
| | O: 0.99% H: 0.0% C: 0.0%

therapeutics
AbbVie to Present at the Cowen 42nd Annual Health Care Conference
Published: 2022-03-01 (Crawled : 14:30) - biospace.com/
ABBV | News | $167.83 -1.01% 0.0% 4M twitter stocktwits trandingview |
Health Technology
| | O: 0.99% H: 0.0% C: 0.0%

health conference
Ascletis Announces Submission of Marketing Authorization Applications for Ritonavir in Eight Additional European Countries
Published: 2022-03-01 (Crawled : 10:00) - prnewswire.com
ABBV | News | $167.83 -1.01% 0.0% 4M twitter stocktwits trandingview |
Health Technology
| | O: 0.99% H: 0.0% C: 0.0%

europe application authorization submission
Gainers vs Losers
65% 35%

Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 210M twitter stocktwits trandingview |
Consumer Services

BOF | $1.99 70.09% 41.21% 110M twitter stocktwits trandingview |

ILAG | $0.51 6.03% 40.62% 1.7M twitter stocktwits trandingview |

LICN | $0.941 68.04% 40.49% 15M twitter stocktwits trandingview |

AMST | $3.31 65.5% 39.58% 70M twitter stocktwits trandingview |
Technology Services

MTC | $3.615 61.38% 38.04% 9.3M twitter stocktwits trandingview |
Technology Services

WIMI | $1.15 58.53% 36.92% 19M twitter stocktwits trandingview |
Technology Services

AIH | $0.45 12.5% 30.92% 320K twitter stocktwits trandingview |
Health Services

MULN | News | $3.78 38.46% 27.78% 13M twitter stocktwits trandingview |
Information

RILY | $29.86 37.48% 27.26% 12M twitter stocktwits trandingview |
Finance


Your saved searches
Save your searches and get alerts when important news are released.